Release Date: 02/10/17 08:10 Summary: Updated Product Disclosure Statement Price Sensitive: No Download Document 10.29MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%